(8 years, 10 months ago)
Commons ChamberUrgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
One of my constituents, Sue Wathen, is trying to access the Harvoni drug, but it is proving incredibly difficult, because she has not developed cirrhosis. She does, however, have an underlying medical condition that is being exacerbated by the contaminated blood. Much is being reported about greater access from February. Is that the case and will Mrs Wathen be able to access the treatment she so desperately needs? I would love a yes or no answer, because it is incredibly frustrating.
I would never give a yes or no answer to the individual health problems of a constituent I do not know, and I am not a clinician, but if my hon. Friend would like to write to me, I will certainly make sure I give an individualised response. Ultimately, however, the right clinical route for any one individual would come at the suggestion of their consultant hepatologist. Towards the end of November, NICE published new guidelines on three more drug treatments, so the drug landscape for hepatitis C is changing rapidly, but I am happy to ensure that hon. Members are kept fully informed. As I said in a previous debate, if people are concerned that their constituents are not aware of what is out there or do not feel they are getting the support they need to access treatment in line with the NICE guidance, we can offer advice to Members on how to make sure that happens. However, I am well aware of the general point he makes.